As primary care doctors, treating patients with Type 2 DM is our bread and butter, as the majority of them seek treatment at health clinics. It is true that some of the patients have managed to achieve good glycaemic control, but more than half of them still have poorly controlled blood sugar as compared to the clinical practice guideline recommendation [1]. And usually, the first thing that comes to our mind when seeing these patients is to increase the dosage of anti-diabetic medication that they are currently on or to add another agent, including insulin. We also frequently tell them that the high blood sugar level is not surprising, as such is the nature of diabetes, where the worsening of blood sugar is expected due to progressive deterioration of pancreatic beta cell function.